We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Strength Seen in Oscar Health (OSCR): Can Its 18.7% Jump Turn into More Strength?
Read MoreHide Full Article
Oscar Health, Inc. (OSCR - Free Report) shares rallied 18.7% in the last trading session to close at $20.67. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock's 4.7% loss over the past four weeks.
Oscar noted about 11.6% of household income is spent on employer plans. Thus, there remains a sea of opportunities for Oscar to address consumers’ expectations for affordable healthcare. By leveraging deep ACA marketplace expertise, OSCR is well-poised to address this healthcare trend.
Its growth strategy encompasses having a market-leading, sustainable, scalable operations, build on superior member experience, accelerate technology developments and innovate market offerings to expand the individual market should drive performance.
OSCR targets at least 20% revenue CAGR and 5% operating margin by 2027 with upside if enhanced subsidies are extended. It expects pricing discipline and administrative cost efficiencies to drive margin expansion.
This company is expected to post quarterly loss of $0.20 per share in its upcoming report, which represents a year-over-year change of +31%. Revenues are expected to be $2.32 billion, up 61.4% from the year-ago quarter.
While earnings and revenue growth expectations are important in evaluating the potential strength in a stock, empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.
For Oscar Health, the consensus EPS estimate for the quarter has been revised 3.4% lower over the last 30 days to the current level. And a negative trend in earnings estimate revisions doesn't usually translate into price appreciation. So, make sure to keep an eye on OSCR going forward to see if this recent jump can turn into more strength down the road.
Oscar Health is a member of the Zacks Insurance - Multi line industry. One other stock in the same industry, Assurant (AIZ - Free Report) , finished the last trading session 1.3% lower at $189.32. AIZ has returned 4% over the past month.
Assurant's consensus EPS estimate for the upcoming report has changed +2.9% over the past month to $3.29. Compared to the company's year-ago EPS, this represents a change of -23.3%. Assurant currently boasts a Zacks Rank of #1 (Strong Buy).
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Strength Seen in Oscar Health (OSCR): Can Its 18.7% Jump Turn into More Strength?
Oscar Health, Inc. (OSCR - Free Report) shares rallied 18.7% in the last trading session to close at $20.67. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock's 4.7% loss over the past four weeks.
Oscar noted about 11.6% of household income is spent on employer plans. Thus, there remains a sea of opportunities for Oscar to address consumers’ expectations for affordable healthcare. By leveraging deep ACA marketplace expertise, OSCR is well-poised to address this healthcare trend.
Its growth strategy encompasses having a market-leading, sustainable, scalable operations, build on superior member experience, accelerate technology developments and innovate market offerings to expand the individual market should drive performance.
OSCR targets at least 20% revenue CAGR and 5% operating margin by 2027 with upside if enhanced subsidies are extended. It expects pricing discipline and administrative cost efficiencies to drive margin expansion.
This company is expected to post quarterly loss of $0.20 per share in its upcoming report, which represents a year-over-year change of +31%. Revenues are expected to be $2.32 billion, up 61.4% from the year-ago quarter.
While earnings and revenue growth expectations are important in evaluating the potential strength in a stock, empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.
For Oscar Health, the consensus EPS estimate for the quarter has been revised 3.4% lower over the last 30 days to the current level. And a negative trend in earnings estimate revisions doesn't usually translate into price appreciation. So, make sure to keep an eye on OSCR going forward to see if this recent jump can turn into more strength down the road.
The stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>
Oscar Health is a member of the Zacks Insurance - Multi line industry. One other stock in the same industry, Assurant (AIZ - Free Report) , finished the last trading session 1.3% lower at $189.32. AIZ has returned 4% over the past month.
Assurant's consensus EPS estimate for the upcoming report has changed +2.9% over the past month to $3.29. Compared to the company's year-ago EPS, this represents a change of -23.3%. Assurant currently boasts a Zacks Rank of #1 (Strong Buy).